|
1
|
Oskarsson T: Extracellular matrix
components in breast cancer progression and metastasis. Breast.
22:(Suppl 2). S66–S72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lu P, Weaver VM and Werb Z: The
extracellular matrix: A dynamic niche in cancer progression. J Cell
Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ioachim E, Charchanti A, Briasoulis E,
Karavasilis V, Tsanou H, Arvanitis DL, Agnantis NJ and Pavlidis N:
Immunohistochemical expression of extracellular matrix components
tenascin, fibronectin, collagen type IV and laminin in breast
cancer: Their prognostic value and role in tumour invasion and
progression. Eur J Cancer. 38:2362–2370. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bae YK, Kim A, Kim MK, Choi JE, Kang SH
and Lee SJ: Fibronectin expression in carcinoma cells correlates
with tumor aggressiveness and poor clinical outcome in patients
with invasive breast cancer. Hum Pathol. 44:2028–2037. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou Z, Qutaish M, Han Z, Schur RM, Liu Y,
Wilson DL and Lu ZR: MRI detection of breast cancer micrometastases
with a fibronectin-targeting contrast agent. Nat Commun.
6:79842015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sceneay J, Smyth MJ and Möller A: The
pre-metastatic niche: Finding common ground. Cancer Metastasis Rev.
32:449–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barkan D, Green JE and Chambers AF:
Extracellular matrix: A gatekeeper in the transition from dormancy
to metastatic growth. Eur J Cancer. 46:1181–1188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalluri R: EMT: When epithelial cells
decide to become mesenchymal-like cells. J Clin Invest.
119:1417–1419. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park J and Schwarzbauer JE: Mammary
epithelial cell interactions with fibronectin stimulate
epithelial-mesenchymal transition. Oncogene. 33:1649–1657. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hood JL, Brooks WH and Roszman TL:
Subcellular mobility of the calpain/calpastatin network: An
organelle transient. Bioessays. 28:850–859. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Storr SJ, Carragher NO, Frame MC, Parr T
and Martin SG: The calpain system and cancer. Nat Rev Cancer.
11:364–374. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Storr SJ, Thompson N, Pu X, Zhang Y and
Martin SG: Calpain in breast cancer: Role in disease progression
and treatment response. Pathobiology. 82:133–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shiba E, Kambayashi JI, Sakon M, Kawasaki
T, Kobayashi T, Koyama H, Yayoi E, Takatsuka Y and Takai SI:
Ca²+;-dependent neutral protease (Calpain) activity in
breast cancer tissue and estrogen receptor status. Breast Cancer.
3:13–17. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Libertini SJ, Robinson BS, Dhillon NK,
Glick D, George M, Dandekar S, Gregg JP, Sawai E and Mudryj M:
Cyclin E both regulates and is regulated by calpain 2, a protease
associated with metastatic breast cancer phenotype. Cancer Res.
65:10700–10708. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Storr SJ, Lee KW, Woolston CM, Safuan S,
Green AR, Macmillan RD, Benhasouna A, Parr T, Ellis IO and Martin
SG: Calpain system protein expression in basal-like and
triple-negative invasive breast cancer. Ann Oncol. 23:2289–2296.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Franco SJ, Rodgers MA, Perrin BJ, Han J,
Bennin DA, Critchley DR and Huttenlocher A: Calpain-mediated
proteolysis of talin regulates adhesion dynamics. Nat Cell Biol.
6:977–983. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chan KT, Bennin DA and Huttenlocher A:
Regulation of adhesion dynamics by calpain-mediated proteolysis of
focal adhesion kinase (FAK). J Biol Chem. 285:11418–11426. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cortesio CL, Chan KT, Perrin BJ, Burton
NO, Zhang S, Zhang ZY and Huttenlocher A: Calpain 2 and PTP1B
function in a novel pathway with Src to regulate invadopodia
dynamics and breast cancer cell invasion. J Cell Biol. 180:957–971.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hoskin V, Szeto A, Ghaffari A, Greer PA,
Côté GP and Elliott BE: Ezrin regulates focal adhesion and
invadopodia dynamics by altering calpain activity to promote breast
cancer cell invasion. Mol Biol Cell. 26:3464–3479. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wells A, Kassis J, Solava J, Turner T and
Lauffenburger DA: Growth factor-induced cell motility in tumor
invasion. Acta Oncol. 41:124–130. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Keshamouni VG, Jagtap P, Michailidis G,
Strahler JR, Kuick R, Reka AK, Papoulias P, Krishnapuram R,
Srirangam A, Standiford TJ, et al: Temporal quantitative proteomics
by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis
identify post-transcriptional modulation of actin-cytoskeleton
regulators during TGF-beta-induced epithelial-mesenchymal
transition. J Proteome Res. 8:35–47. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meng XN, Jin Y, Yu Y, Bai J, Liu GY, Zhu
J, Zhao YZ, Wang Z, Chen F, Lee KY and Fu SB: Characterisation of
fibronectin-mediated FAK signalling pathways in lung cancer cell
migration and invasion. Br J Cancer. 101:327–334. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li C, Zhao Y, Yang D, Yu Y, Guo H, Zhao Z,
Zhang B and Yin X: Inhibitory effects of kaempferol on the invasion
of human breast carcinoma cells by downregulating the expression
and activity of matrix metalloproteinase-9. Biochem Cell Biol.
93:16–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Drasin DJ, Robin TP and Ford HL: Breast
cancer epithelial-to-mesenchymal transition: Examining the
functional consequences of plasticity. Breast Cancer Res.
13:2262011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Franco SJ and Huttenlocher A: Regulating
cell migration: Calpains make the cut. J Cell Sci. 118:3829–3838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Frame MC, Fincham VJ, Carragher NO and
Wyke JA: v-Src's hold over actin and cell adhesions. Nat Rev Mol
Cell Biol. 3:233–245. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carragher NO, Levkau B, Ross R and Raines
EW: Degraded collagen fragments promote rapid disassembly of smooth
muscle focal adhesions that correlates with cleavage of pp125(FAK),
paxillin and talin. J Cell Biol. 147:619–630. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Joyce JA: Therapeutic targeting of the
tumor microenvironment. Cancer Cell. 7:513–520. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fernandez-Garcia B, Eiró N, Marín L,
González-Reyes S, González LO, Lamelas ML and Vizoso FJ: Expression
and prognostic significance of fibronectin and matrix
metalloproteases in breast cancer metastasis. Histopathology.
64:512–522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Balanis N, Wendt MK, Schiemann BJ, Wang Z,
Schiemann WP and Carlin CR: Epithelial to mesenchymal transition
promotes breast cancer progression via a fibronectin-dependent
STAT3 signaling pathway. J Biol Chem. 288:17954–17967. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pereira IT, Ramos EA, Costa ET, Camargo
AA, Manica GC, Klassen LM, Chequin A, Braun-Prado K, Fde Pedrosa O,
Souza EM, et al: Fibronectin affects transient MMP2 gene expression
through DNA demethylation changes in non-invasive breast cancer
cell lines. PLoS One. 9:e1058062014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Femel J, Huijbers EJ, Saupe F, Cedervall
J, Zhang L, Roswall P, Larsson E, Olofsson H, Pietras K, Dimberg A,
et al: Therapeutic vaccination against fibronectin ED-A attenuates
progression of metastatic breast cancer. Oncotarget. 5:12418–12427.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gora J and Latajka R: Involvement of
cysteine proteases in cancer. Curr Med Chem. 22:944–957. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Leloup L and Wells A: Calpains as
potential anti-cancer targets. Expert Opin Ther Targets.
15:309–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ho WC, Pikor L, Gao Y, Elliott BE and
Greer PA: Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling
pathway in mammary carcinoma. J Biol Chem. 287:15458–15465. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Goll DE, Thompson VF, Li H, Wei W and Cong
J: The calpain system. Physiol Rev. 83:731–801. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Legate KR, Wickström SA and Fässler R:
Genetic and cell biological analysis of integrin outside-in
signaling. Genes Dev. 23:397–418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Carragher NO, Fincham VJ, Riley D and
Frame MC: Cleavage of focal adhesion kinase by different proteases
during SRC-regulated transformation and apoptosis. Distinct roles
for calpain and caspases. J Biol Chem. 276:4270–4275. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ilic D, Almeida EA, Schlaepfer DD, Dazin
P, Aizawa S and Damsky CH: Extracellular matrix survival signals
transduced by focal adhesion kinase suppress p53-mediated
apoptosis. J Cell Biol. 143:547–560. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kim NG and Gumbiner BM: Adhesion to
fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway.
J Cell Biol. 210:503–515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bedi U, Mishra VK, Wasilewski D, Scheel C
and Johnsen SA: Epigenetic plasticity: A central regulator of
epithelial-to-mesenchymal transition in cancer. Oncotarget.
5:2016–2029. 2014. View Article : Google Scholar : PubMed/NCBI
|
